Predictive factors of clot propagation in patients with superficial venous thrombosis towards deep venous thrombosis and pulmonary embolism: a systematic review and meta-analysis.
epidemiologic studies
systematic review
thromboembolism
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
medline:
18
4
2024
pubmed:
17
4
2024
entrez:
16
4
2024
Statut:
epublish
Résumé
A subset of patients with superficial venous thrombosis (SVT) experiences clot propagation towards deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The aim of this systematic review is to identify all clinically relevant cross-sectional and prognostic factors for predicting thrombotic complications in patients with SVT. Systematic review. PubMed/MEDLINE and Embase were systematically searched until 3 March 2023. Original research studies with patients with SVT, DVT and/or PE as the outcome and presenting cross-sectional or prognostic predictive factors. The CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling (CHARMS) checklist for prognostic factor studies was used for systematic extraction of study characteristics. Per identified predictive factor, relevant estimates of univariable and multivariable predictor-outcome associations were extracted, such as ORs and HRs. Estimates of association for the most frequently reported predictors were summarised in forest plots, and meta-analyses with heterogeneity were presented. The Quality in Prognosis Studies (QUIPS) tool was used for risk of bias assessment and Grading of Recommendations, Assessment, Development and Evaluations (GRADE) for assessing the certainty of evidence. Twenty-two studies were included (n=10 111 patients). The most reported predictive factors were high age, male sex, history of venous thromboembolism (VTE), absence of varicose veins and cancer. Pooled effect estimates were heterogenous and ranged from OR 3.12 (95% CI 1.75 to 5.59) for the cross-sectional predictor cancer to OR 0.92 (95% CI 0.56 to 1.53) for the prognostic predictor high age. The level of evidence was rated very low to low. Most studies were scored high or moderate risk of bias. Although the pooled estimates of the predictors high age, male sex, history of VTE, cancer and absence of varicose veins showed predictive potential in isolation, variability in study designs, lack of multivariable adjustment and high risk of bias prevent firm conclusions. High-quality, multivariable studies are necessary to be able to identify individual SVT risk profiles. CRD42021262819.
Identifiants
pubmed: 38626964
pii: bmjopen-2023-074818
doi: 10.1136/bmjopen-2023-074818
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e074818Informations de copyright
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Vasc Surg. 2003 Nov;38(5):944-9
pubmed: 14603198
N Engl J Med. 2010 Sep 23;363(13):1222-32
pubmed: 20860504
Vasc Med. 2004 Feb;9(1):1-6
pubmed: 15230481
PLoS One. 2012;7(2):e32844
pubmed: 22393453
J Vasc Surg. 1999 Dec;30(6):1113-5
pubmed: 10587397
J Thromb Haemost. 2014 Jun;12(6):831-8
pubmed: 24679145
Stat Med. 2001 Dec 30;20(24):3875-89
pubmed: 11782040
J Vasc Surg. 2012 Oct;56(4):1032-8.e1
pubmed: 22832262
J Thromb Haemost. 2012 Jun;10(6):1004-11
pubmed: 22429908
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Int Angiol. 2009 Oct;28(5):400-8
pubmed: 19935595
Diagn Progn Res. 2021 Aug 18;5(1):15
pubmed: 34404480
Ann Intern Med. 2010 Feb 16;152(4):218-24
pubmed: 20157136
Thromb Res. 2015 Nov;136(5):938-42
pubmed: 26421909
BMJ. 2015 Jun 22;350:h2039
pubmed: 26099257
BMJ. 2019 Jan 30;364:k4597
pubmed: 30700442
Surgery. 1991 Jul;110(1):42-6
pubmed: 1866693
Vasc Specialist Int. 2018 Mar;34(1):1-9
pubmed: 29629359
Curr Opin Pulm Med. 2003 Sep;9(5):393-7
pubmed: 12904709
Blood. 2015 Jan 8;125(2):229-35
pubmed: 25398934
Arch Intern Med. 1997 Sep 8;157(16):1822-4
pubmed: 9290540
Thromb Res. 2022 Dec;220:145-152
pubmed: 36370650
J Thromb Thrombolysis. 2019 Jan;47(1):96-101
pubmed: 30317413
Int Angiol. 2013 Aug;32(4):410-6
pubmed: 23822944
J Thromb Thrombolysis. 2017 Jan;43(1):31-37
pubmed: 27565478
J Clin Epidemiol. 2020 May;121:62-70
pubmed: 31982539
Thromb Haemost. 2019 Mar;119(3):479-489
pubmed: 30716777
Eur J Vasc Endovasc Surg. 2021 Aug;62(2):241-249
pubmed: 34210599
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Eur J Vasc Endovasc Surg. 2005 Jan;29(1):10-7
pubmed: 15570265
J Thromb Haemost. 2017 Nov;15(11):2176-2183
pubmed: 28871623
J Vasc Surg. 1993 Jul;18(1):70-3
pubmed: 8326661
Arch Dermatol. 2009 Jul;145(7):753-7
pubmed: 19620555
J Fam Pract. 2006 Jan;55(1):52-7
pubmed: 16388768
Thromb Haemost. 2011 Jan;105(1):31-9
pubmed: 20886192
Thromb Res. 2014 Feb;133(2):196-202
pubmed: 24365043